Twenty Years of Cytoreductive Surgery for Advanced Endometrial Carcinoma: A Single-Center Retrospective Cohort Study
Cancers · 16.05.2026 · 18 (10) · 1617
DOI: 10.3390/cancers18101617 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancers, online erschienen am 16.05.2026. Verfasst von Britt Kilkens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Endometrial carcinoma (EC), the most common gynecological malignancy, is associated with unfavorable survival in advanced stages. Treatment strategies now include cytoreductive surgery (CRS) and (neo)adjuvant chemotherapy, but survival rates remain limited. This study evaluates overall survival (OS) and surgical outcomes, including outcomes of CRS and surgical complications, over a 20-year period at the Erasmus MC.
Methods
This retrospective cohort study includes women diagnosed with FIGO stage III or IV EC between 2000 and 2020 who received treatment at the Erasmus MC. Data were collected from the Netherlands Comprehensive Cancer Organization and supplemented by medical record reviews. Statistical analyses were conducted to evaluate differences in OS based on FIGO stage, histological type, molecular characteristics, CRS outcome, and type of CRS.
Results
A total of 188 patients were included, with a median age of 66 years. Most patients received surgery and additional chemotherapy and radiotherapy. A total of 64 patients (59.3%) underwent primary CRS, and 44 patients (40.7%) underwent interval CRS. Patients with complete CRS had a significant survival advantage over patients with optimal and incomplete CRS (HR 0.56; 95% CI 0.33–0.96, p = 0.036). Comparison between primary and interval CRS revealed no significant difference in OS (HR 1.42; 95% CI 0.82–2.44, p = 0.207). Surgical complications occurred in 33.1% of patients, with infections most common. Two patients died from severe complications.
Conclusions
This study highlights the predominant role of surgery in the management of advanced EC. Complete CRS is often achievable and offers significant survival advantage. However, approximately one-third of patients experience surgical complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
- Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
- Department of Radiotherapy, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
ORCID-Profile: Britt Kilkens, Ingrid Boere, Heleen van Beekhuizen
Zitieren
APA
Kilkens, B., Roes, E. M., Boere, I., Mens, J. W., & van Beekhuizen, H. (2026). Twenty Years of Cytoreductive Surgery for Advanced Endometrial Carcinoma: A Single-Center Retrospective Cohort Study. Cancers, 18(10), 1617. https://doi.org/10.3390/cancers18101617
Vancouver
Kilkens B, Roes EM, Boere I, Mens JW, van Beekhuizen H. Twenty Years of Cytoreductive Surgery for Advanced Endometrial Carcinoma: A Single-Center Retrospective Cohort Study. Cancers. 2026;18(10):1617. doi:10.3390/cancers18101617
BibTeX
@article{Kilkens2026,
author = {Kilkens, Britt and Roes, Eva Maria and Boere, Ingrid and Mens, Jan-Willem and van Beekhuizen, Heleen},
title = {Twenty Years of Cytoreductive Surgery for Advanced Endometrial Carcinoma: A Single-Center Retrospective Cohort Study},
journal = {Cancers},
year = {2026},
volume = {18},
number = {10},
pages = {1617},
doi = {10.3390/cancers18101617}
}
EUVIMED